NHEJ vs HDR CRISPR: How Cells Repair DNA After a Cut

NHEJ (non-homologous end joining) reconnects broken DNA ends directly, often introducing small insertions or deletions, while HDR (homology-directed repair) rebuilds the break site using a template with matching sequence, enabling precise edits. For CRISPR teams, which pathway the cell uses after the double-strand break determines whether the experiment produces a knockout or a knock-in.

The repair decision is not something researchers control directly; it is a competition between the cell's own repair pathways. Understanding that competition explains why knockouts are relatively straightforward and precise knock-ins are harder, and why experimental design must steer the outcome toward the desired pathway. This guide covers how each pathway works and what the difference means for gene editing strategy.

The Two Repair Pathways in One Comparison

How NHEJ Produces Knockouts

After Cas9 cuts both strands, the cell can rejoin the ends through NHEJ, a process that is fast and active but not always clean. The repair machinery trims or adds bases at the junction, creating small insertions or deletions known as indels. When an indel lands in a coding exon, it often shifts the reading frame, producing a premature stop codon and a functional knockout.

This is why standard CRISPR knockouts are comparatively efficient: NHEJ is the dominant repair pathway, and any frame-shifting indel achieves the goal. The trade-off is that the exact mutation is not controlled, so knockout alleles vary between cells and must be confirmed by sequencing. A knockout is easy to make and needs verification to describe.

How HDR Produces Precise Edits

Homology-directed repair rebuilds the break using a donor template whose ends match the sequences flanking the cut. The cell copies the template across the break, allowing a researcher to insert a new sequence, correct a mutation, or add a tag precisely. This is the pathway behind knock-ins and precise genome corrections.

HDR is constrained in two important ways. It requires a donor template, typically a single-stranded oligo or a plasmid with homology arms, and it is mostly active during S and G2 phases of the cell cycle when a sister chromatid can serve as a natural template. Because NHEJ competes for the same break and is active more broadly, HDR outcomes are typically less frequent, which is why precise editing experiments often include measures to favor the pathway or select for the desired event.

Why Knock-Ins Are Harder Than Knockouts

The difficulty gap between knockouts and knock-ins follows directly from the pathway competition. A knockout only needs NHEJ to introduce a frame-shifting indel, and NHEJ is the dominant pathway. A knock-in needs HDR to win at the break site, which happens less often and competes with the same indel-generating NHEJ.

Researchers steer this competition with several tools: delivering the donor template at the right time, using modified Cas variants or cell cycle staging to favor HDR, or selecting for cells that incorporated the desired edit. None of these removes the fundamental asymmetry; they shift the odds. Planning a knock-in therefore means planning for enrichment and verification, not expecting HDR to dominate on its own.

Choosing the Pathway for Your Editing Goal

The experimental goal dictates the pathway. If the goal is to disrupt a gene, design for NHEJ-mediated knockout and verify the indel by sequencing. If the goal is to insert or correct sequence, design for HDR with a well-constructed donor template and plan for the lower efficiency. Mixing the goals, trying to achieve a precise change without a donor template, is a common source of failed editing campaigns.

The donor template itself deserves careful design: homology arms long enough for efficient repair, the intended edit placed near the cut site, and silent changes that block re-cutting by Cas9 after repair. When the pathway strategy and template design are documented alongside the guide and the verification plan, the whole editing workflow becomes reviewable. For teams that want CRISPR design and verification context connected, ZettaCRISPR within the Zettalab workspace supports structured guide and primer design, and the broader platform links the design to the sequencing verification that confirms the repair outcome.

FAQ

What is the difference between NHEJ and HDR?

NHEJ reconnects broken DNA ends directly and usually introduces small insertions or deletions, which makes it the pathway behind gene knockouts. HDR rebuilds the break site using a donor template with matching flanking sequence, enabling precise insertions or corrections. NHEJ needs no template and dominates most of the cell cycle; HDR needs a donor and is largely restricted to S and G2 phase.

Which repair pathway does CRISPR use?

CRISPR itself does not choose the pathway; the cell does. After Cas9 creates a double-strand break, the cell's repair machinery competes for it, with NHEJ generally dominating and HDR occurring less frequently. Experimental design, donor template delivery, cell cycle timing, and selection all influence which pathway wins, which is why knockouts are easier to achieve than precise knock-ins.

Why is HDR less efficient than NHEJ?

Two reasons: HDR requires a donor template that must be present at the break site, and its activity is largely limited to S and G2 cell cycle phases, while NHEJ is active through most of the cycle. The same break can be resolved by either pathway, so NHEJ, being faster and more broadly active, typically wins the competition unless the experiment actively favors HDR.

How can I increase HDR efficiency in a knock-in experiment?

Common approaches include delivering the donor template in an optimized form, timing the edit to when cells are in S or G2 phase, using Cas variants or inhibitors that shift the balance toward HDR, and applying selection or screening for cells that incorporated the edit. Even with these measures, HDR outcomes remain less frequent than NHEJ, so plan for enrichment and confirm the edit by sequencing.

Conclusion

NHEJ and HDR are the two repair pathways competing for every CRISPR cut: NHEJ makes fast, imprecise indels that produce knockouts, while HDR makes template-guided precise edits for knock-ins. Designing the experiment around the desired pathway, and verifying the actual outcome by sequencing, is what separates planned edits from hopes. To connect CRISPR design with verification, explore Zettalab's cloud-based R&D lab platform.